Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Genentech-s-Columvi-Meets-Primary-Endpoint-of-Overall-Survival-in-People-With-Relapsed-or-Refracto-46431916/?utm_source=whatsapp&utm_medium=social&utm_campaign=share